These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 3011900)

  • 21. Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.
    Morigi M; Macconi D; Riccardi E; Boccardo P; Zilio P; Bertani T; Remuzzi G
    J Pharmacol Exp Ther; 1991 Aug; 258(2):601-6. PubMed ID: 1650836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes.
    Henson PM; Pinckard RN
    Monogr Allergy; 1977; 12():13-26. PubMed ID: 335211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and complement-induced pulmonary hypertension in sheep.
    Smallbone BW; Taylor NE; McDonald JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1035-40. PubMed ID: 2821222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
    Hellewell PG; Williams TJ
    J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
    Levine L
    Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
    Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
    J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
    Beauchamp MH; Marrache AM; Hou X; Gobeil F; Bernier SG; Lachapelle P; Abran D; Quiniou C; Brault S; Peri KG; Roberts J; Almazan G; Varma DR; Chemtob S
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3327-37. PubMed ID: 12356842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675.
    Handley DA; Van Valen RG; Winslow CM; Tomesch JC; Saunders RN
    Thromb Haemost; 1987 Apr; 57(2):187-90. PubMed ID: 3037718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
    Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
    Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat.
    Souza DG; Cara DC; Cassali GD; Coutinho SF; Silveira MR; Andrade SP; Poole SP; Teixeira MM
    Br J Pharmacol; 2000 Dec; 131(8):1800-8. PubMed ID: 11139461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
    Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
    J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of PAF-acether in the anaphylactic shock in the rat.
    Damas J
    J Lipid Mediat; 1989; 1(3):161-70. PubMed ID: 2519891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.
    Ponpipom MM; Hwang SB; Doebber TW; Acton JJ; Alberts AW; Biftu T; Brooker DR; Bugianesi RL; Chabala JC; Gamble NL
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1213-20. PubMed ID: 2829894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of platelet-activating factor (PAF) receptor in the rat brain.
    Bito H; Kudo Y; Shimizu T
    J Lipid Mediat; 1993; 6(1-3):169-74. PubMed ID: 8395241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.